FC
GILD icon

Financial Consulate’s Gilead Sciences GILD Stock Holding History

Financial Consulate’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.7K Sell
267
-11
-4% -$1.45K ﹤0.01% 413
2026
Q1 		$38.7K Buy
278
+42
+18% +$5.88K ﹤0.01% 369
2025
Q4 		$28.9K Buy
236
+109
+86% +$13.2K ﹤0.01% 406
2025
Q3 		$14.1K Buy
+127
New +$14.4K ﹤0.01% 509

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Financial Consulate's GILD Position: Q2 2026 in Review

Financial Consulate reduced its Gilead Sciences (GILD) stake by 4% in Q2 2026, selling an estimated $1.45K and leaving 267 shares worth $33.7K. The position accounts for ﹤0.01% of the portfolio, ranked #413.

Financial Consulate first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. The position peaked at $38.7K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Financial Consulate held 267 shares of Gilead Sciences worth $33.7K as of Q2 2026.
  • Financial Consulate sold 11 Gilead Sciences shares in Q2 2026, an estimated $1.45K.
  • Gilead Sciences made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #413 holding.
  • Financial Consulate first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • Financial Consulate's Gilead Sciences position peaked at $38.7K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.